Marchex, Inc. - Class B Common Stock (MCHX)

Marchex reports Q3 2025 results, missing revenue but meeting profit targets. The stock rose on news of its strategic Archenia acquisition and a positive 2026 growth outlook.

Marchex (MCHX) Q3 2025 Earnings Call Transcript

MCHX stock results show that Marchex missed on revenue for the fourth quarter of 2023.

Marchex posted mixed Q2 2025 results with revenue missing estimates but adjusted EBITDA and EPS improving. AI-driven growth and new partnerships signal future potential despite short-term challenges.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

MCHX stock results show that Marchex met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.